Evidence map›Paper›PMID 18648741›Full record

ArticleJournal of gastroenterology2008

Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines.

Hiroshi Oshio, Takaaki Abe, Tohru Onogawa, Hideo Ohtsuka, Takeaki Sato, Takayuki Ii, Kouji Fukase, Mitsuhisa Muto, Yu Katayose, Masaya Oikawa and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Role of bile acids in colon carcinogenesis.World journal of clinical cases · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  14. Article
  15. Article
  16. Gemfibrozil, stretching arms beyond lipid lowering.Immunopharmacology and immunotoxicology · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hiroshi OshioDivision of Gastroenterological Surgery, Department of Surgery, Tohoku University Graduate School of Medical Science, 1-1 Seiryo-machi, Aoba, Sendai 980-8574, Japan.
Takaaki Abe
Tohru Onogawa
Hideo Ohtsuka
Takeaki Sato
Takayuki Ii
Kouji Fukase
Mitsuhisa Muto
Yu Katayose
Masaya Oikawa
Toshiki Rikiyama
Shinichi Egawa
Michiaki Unno
Tohoku University · JPJapan Science and Technology Agency · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence is accumulating that bile acids are involved in colon cancer development, but their molecular mechanisms remain unexplored. Bile acid has been reported to be associated with induction of the cyclooxygenase-2 (COX-2) gene. Because the human liver-specific organic anion transporter-2 (LST-2/OATP8/OATP1B3) is expressed in gastrointestinal cancers and might transport bile acids to the intracellular space, we studied the molecular mechanisms by which bile acids induce the transcription of COX-2, and the role of LST-2 in colonic cell lines.

methodsTranscriptional activity of COX-2 was measured using a human COX-2 promoter-luciferase assay under various concentrations of bile acids. Electrophoresis mobility shift assays (EMSAs) for peroxisome proliferators-activated receptor (PPAR) alpha and cyclic AMP responsive element (CRE) were performed.

resultsThe COX-2 promoter was induced by lithocholic acid (LCA), deoxycholic acid (DCA), and chenodeoxycholic acid (CDCA). Deletion and site-directed mutation analyses showed that CRE is the responsive element for LCA. An adenovirus expression system revealed that LST-2 is responsible for induction of COX-2. By EMSA using oligonucleotides of CRE, we observed formation of a specific protein-DNA complex, which was inhibited by a specific antibody against PPARalpha and CRE. A PPARalpha-specific agonist induced transcription of COX-2.

conclusionThese results indicate that COX-2 is transcriptionally activated by the addition of LCA, CDCA, and DCA and that LST-2 plays an important role by transporting bile acid to the intracellular space. Moreover, LCA-dependent COX-2 gene activation consists of a transcriptional complex including PPARalpha and CRE-binding protein. Thus, this induction of COX-2 may participate in carcinogenesis and progression of colorectal cancer cells.

Indexed as

AdenoviridaeBile Acids and SaltsCell Line, TumorColorectal NeoplasmsCyclic AMP Response Element-Binding ProteinCyclooxygenase 2Electrophoretic Mobility Shift AssayGene Expression RegulationHumansLithocholic AcidOrganic Anion Transporters, Sodium-IndependentPPAR alphaPromoter Regions, GeneticSolute Carrier Organic Anion Transporter Family Member 1B3Transcriptional ActivationTranscription, GeneticBile Acids and SaltsCyclic AMP Response Element-Binding ProteinCyclooxygenase 2Lithocholic AcidOrganic Anion Transporters, Sodium-IndependentPPAR alphaSLCO1B3 protein, humanSolute Carrier Organic Anion Transporter Family Member 1B3

Identifiers

PMID18648741
OpenAlexW2037500661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.